Kefir

Kefir is the probiotic heavyweight, delivering 10–34 billion colony-forming units per cup across up to 60 unique bacterial and yeast species—a diversity unmatched by any other item on this list, including Kimchi. The kefir grain community includes Lactobacillus kefiranofaciens, L. kefiri, and Saccharomyces cerevisiae, producing lactic acid, acetic acid, kefiran exopolysaccharide, and carbon dioxide. A 2025 meta-analysis of 23 human studies found strong evidence that kefir combined with standard antibiotic therapy improves H. pylori eradication rates by 60%—one of the most clinically actionable findings, as H. pylori infects 44% of the global population and is a primary cause of gastric cancer. A 2025 RCT documented that daily kefir consumption increased Bifidobacterium by 30%, Prevotella by 20%, and Akkermansia muciniphila while decreasing Enterobacteriaceae by 15%. Kefiran demonstrates antioxidant and anti-inflammatory properties in preclinical research. Kefir contains 55% less lactose than milk, making it tolerable for most lactose-intolerant individuals. Prioritize this for those undergoing antibiotic therapy or wanting maximum CFU diversity, but avoid during pregnancy due to 0.5–2% alcohol content.